Company intelligence / Profile preview

GAIA BioMaterials

Helsingborg, Skåne, Swedengaiabiomaterials.com ↗

Ownership: Private
Development stage: Commercial

Overview

GAIA BioMaterials has developed and commercialized Biodolomer®, a fully compostable biomaterial that serves as an alternative to traditional plastics. The material is certified for compostability by both BPI (USA) and TÜV Austria (EU), produces no microplastics, reduces CO₂ emissions by up to 80% compared to fossil plastics when incinerated, and can be processed using existing plastic manufacturing equipment. The company supplies granules for film blowing, injection molding, sheet extrusion, bottle blowing, thermoforming, tube extrusion, extrusion coating and 3D printing. Products include grocery bags, aprons, food trays/containers/cups/bottles/pots/nets.

Industry: Non-Drug Biotech

Partnerships

OneMed (Customer)Loxy AB (Customer)Laktos Biodeg (Customer)

Beyond the preview

Go deeper on GAIA BioMaterials.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GAIA BioMaterials.

Explore the full profile